fda compounding glp-1 warning letters october 2025 Out of Shortage, Into Controversy: The Fight Over One Year Later, FDA Reorg

Publishers note All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

For patients with hypothyroidism who are not candidates for weight loss injections or prefer alternative approaches, evidence-based lifestyle interventions remain foundational

Anyone with active substance use issues, including alcohol, is not a great candidate for this type of surgery

DiStefano MJ et al

If youve found yourself feeling bloated, uncomfortable, or struggling with fewer or more difficult bowel movements since starting your GLP-1, we want you to know its not just you

Meanwhile, medical benefits continued to cover services delivered by providers